Howard E. Gendelman, M.D. | |
---|---|
Born | March 18, 1954 Philadelphia, Pennsylvania, U.S. |
Alma mater | Muhlenberg College (B.S.) Pennsylvania State University College of Medicine (M.D.) |
Known for | HIV research, Parkinson's research, neuroimmune-pharmacology |
Awards | Startup of the Year 2022 UNeMed; Nebraska Coalition for Lifesaving Cures' 2022 Life Saver Award; 2018 Jewish Federation of Omaha Humanitarian of the Year Award; 2017 Society on NeuroImmune Pharmacology Lifetime Achievement Award; International Society for NeuroVirology's 2016 Pioneer in NeuroVirology; 2000 J. William Fulbright Research Scholar; and others |
Scientific career | |
Fields | Virology, neuroimmunology, neuroscience, pharmacology, therapeutics |
Institutions | Current: University of Nebraska Medical Center Previous: Henry M. Jackson Foundation for the Advancement in Military Medicine Walter Reed Army Institute of Research Uniformed Services University of the Health Sciences Center Johns Hopkins University Albert Einstein College of Medicine |
Website | https://www.unmc.edu/pharmacology/faculty/primary-faculty/gendelman/ |
Howard E. Gendelman (born March 18, 1954) is an American physician-scientist whose research intersects the disciplines of neuroimmunology, pharmacology, and infectious diseases. Gendelman was born in Philadelphia, Pennsylvania. His research is focused on harnessing immune responses for therapeutic gain in HIV/AIDS and Neurodegenerative disease.[1] He is the Margaret R. Larson Professor of infectious diseases and internal medicine at the University of Nebraska Medical Center (UNMC) in Omaha.[2]
He is married with three children and seven grandchildren.[3]